- Home
- LTRY vs NURO Comparison
LTRY vs NURO Comparison
Compare LTRY & NURO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LTRY
- NURO
- Stock Information
- Founded
- LTRY 2015
- NURO 1996
- Country
- LTRY United States
- NURO United States
- Employees
- LTRY N/A
- NURO N/A
- Industry
- LTRY Computer Software: Prepackaged Software
- NURO Medical/Dental Instruments
- Sector
- LTRY Technology
- NURO Health Care
- Exchange
- LTRY Nasdaq
- NURO Nasdaq
- Market Cap
- LTRY N/A
- NURO 8.2M
- IPO Year
- LTRY N/A
- NURO N/A
- Fundamental
- Price
- LTRY $0.49
- NURO $4.42
- Analyst Decision
- LTRY
- NURO
- Analyst Count
- LTRY 0
- NURO 0
- Target Price
- LTRY N/A
- NURO N/A
- AVG Volume (30 Days)
- LTRY 52.0K
- NURO 14.4K
- Earning Date
- LTRY 11-29-2024
- NURO 11-01-2024
- Dividend Yield
- LTRY N/A
- NURO N/A
- EPS Growth
- LTRY N/A
- NURO N/A
- EPS
- LTRY N/A
- NURO N/A
- Revenue
- LTRY $5,723,382.00
- NURO $4,383,614.00
- Revenue This Year
- LTRY N/A
- NURO N/A
- Revenue Next Year
- LTRY N/A
- NURO N/A
- P/E Ratio
- LTRY N/A
- NURO N/A
- Revenue Growth
- LTRY 125.44
- NURO N/A
- 52 Week Low
- LTRY $0.50
- NURO $2.66
- 52 Week High
- LTRY $7.01
- NURO $5.60
- Technical
- Relative Strength Index (RSI)
- LTRY 34.24
- NURO 65.06
- Support Level
- LTRY $0.51
- NURO $3.96
- Resistance Level
- LTRY $0.57
- NURO $4.69
- Average True Range (ATR)
- LTRY 0.03
- NURO 0.22
- MACD
- LTRY 0.01
- NURO 0.04
- Stochastic Oscillator
- LTRY 0.00
- NURO 82.35
About NURO NeuroMetrix Inc.
NeuroMetrix Inc is a commercial-stage healthcare company. Its core business activities are integrated with in-house capabilities spanning product development, manufacturing, regulatory affairs and compliance, sales and marketing, and customer support. The company produces bioelectrical and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. The product line of the company includes Wearable neuro-stimulation therapeutic devices and Point-of-care neuropathy diagnostic tests. The company operates in a single segment being Medical equipment and consumables.